MENU
APRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aprea Therapeutics (APRE) Ownership - Who owns Aprea Therapeutics?

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers... Show more

Profile

Industry
N/A
Address
3805 Old Easton Road
Phone
+1 215 948-4119
Employees
8
Web
https://www.aprea.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.65M
P/E Ratio
N/A
Total Cash
46.47M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
3.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
APRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 215 948-4119
Employees
8
Web
https://www.aprea.com